303 related articles for article (PubMed ID: 24267894)
1. Δ9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling.
Chen R; Zhang J; Fan N; Teng ZQ; Wu Y; Yang H; Tang YP; Sun H; Song Y; Chen C
Cell; 2013 Nov; 155(5):1154-1165. PubMed ID: 24267894
[TBL] [Abstract][Full Text] [Related]
2. Adolescent Δ
Jouroukhin Y; Zhu X; Shevelkin AV; Hasegawa Y; Abazyan B; Saito A; Pevsner J; Kamiya A; Pletnikov MV
Biol Psychiatry; 2019 Jun; 85(11):891-903. PubMed ID: 30219209
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Delta9-THC exposure-impaired hippocampal synaptic plasticity.
Fan N; Yang H; Zhang J; Chen C
J Neurochem; 2010 Feb; 112(3):691-702. PubMed ID: 19912468
[TBL] [Abstract][Full Text] [Related]
4. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.
Laaris N; Good CH; Lupica CR
Neuropharmacology; 2010; 59(1-2):121-7. PubMed ID: 20417220
[TBL] [Abstract][Full Text] [Related]
5. Long-lasting alterations of hippocampal GABAergic neurotransmission in adult rats following perinatal Δ
Beggiato S; Borelli AC; Tomasini MC; Morgano L; Antonelli T; Tanganelli S; Cuomo V; Ferraro L
Neurobiol Learn Mem; 2017 Mar; 139():135-143. PubMed ID: 28104530
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity.
Kotilinek LA; Westerman MA; Wang Q; Panizzon K; Lim GP; Simonyi A; Lesne S; Falinska A; Younkin LH; Younkin SG; Rowan M; Cleary J; Wallis RA; Sun GY; Cole G; Frautschy S; Anwyl R; Ashe KH
Brain; 2008 Mar; 131(Pt 3):651-64. PubMed ID: 18292081
[TBL] [Abstract][Full Text] [Related]
7. Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory.
Ballinger MD; Saito A; Abazyan B; Taniguchi Y; Huang CH; Ito K; Zhu X; Segal H; Jaaro-Peled H; Sawa A; Mackie K; Pletnikov MV; Kamiya A
Neurobiol Dis; 2015 Oct; 82():176-184. PubMed ID: 26093170
[TBL] [Abstract][Full Text] [Related]
8. Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation.
Hoffman AF; Oz M; Yang R; Lichtman AH; Lupica CR
Learn Mem; 2007; 14(1-2):63-74. PubMed ID: 17202425
[TBL] [Abstract][Full Text] [Related]
9. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820
[TBL] [Abstract][Full Text] [Related]
10. Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats.
Zamberletti E; Gabaglio M; Grilli M; Prini P; Catanese A; Pittaluga A; Marchi M; Rubino T; Parolaro D
Pharmacol Res; 2016 Sep; 111():459-470. PubMed ID: 27422357
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Delta9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase.
Takeda S; Yamamoto I; Watanabe K
Toxicology; 2009 May; 259(1-2):25-32. PubMed ID: 19428940
[TBL] [Abstract][Full Text] [Related]
12. A chronic low dose of Δ
Bilkei-Gorzo A; Albayram O; Draffehn A; Michel K; Piyanova A; Oppenheimer H; Dvir-Ginzberg M; Rácz I; Ulas T; Imbeault S; Bab I; Schultze JL; Zimmer A
Nat Med; 2017 Jun; 23(6):782-787. PubMed ID: 28481360
[TBL] [Abstract][Full Text] [Related]
13. CB1-Dependent Long-Term Depression in Ventral Tegmental Area GABA Neurons: A Novel Target for Marijuana.
Friend L; Weed J; Sandoval P; Nufer T; Ostlund I; Edwards JG
J Neurosci; 2017 Nov; 37(45):10943-10954. PubMed ID: 29038246
[TBL] [Abstract][Full Text] [Related]
14. Acute Δ9-tetrahydrocannabinol prompts rapid changes in cannabinoid CB
Bonilla-Del Río I; Puente N; Mimenza A; Ramos A; Serrano M; Lekunberri L; Gerrikagoitia I; Christie BR; Nahirney PC; Grandes P
J Comp Neurol; 2021 Jun; 529(9):2332-2346. PubMed ID: 33368252
[TBL] [Abstract][Full Text] [Related]
15. Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.
Sousa VC; Assaife-Lopes N; Ribeiro JA; Pratt JA; Brett RR; Sebastião AM
Neuropsychopharmacology; 2011 Jan; 36(2):472-87. PubMed ID: 20927050
[TBL] [Abstract][Full Text] [Related]
16. CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ
Han X; He Y; Bi GH; Zhang HY; Song R; Liu QR; Egan JM; Gardner EL; Li J; Xi ZX
Sci Rep; 2017 Sep; 7(1):12315. PubMed ID: 28951549
[TBL] [Abstract][Full Text] [Related]
17. Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway.
Tortoriello G; Morris CV; Alpar A; Fuzik J; Shirran SL; Calvigioni D; Keimpema E; Botting CH; Reinecke K; Herdegen T; Courtney M; Hurd YL; Harkany T
EMBO J; 2014 Apr; 33(7):668-85. PubMed ID: 24469251
[TBL] [Abstract][Full Text] [Related]
18. β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.
Nguyen PT; Schmid CL; Raehal KM; Selley DE; Bohn LM; Sim-Selley LJ
Biol Psychiatry; 2012 Apr; 71(8):714-24. PubMed ID: 22264443
[TBL] [Abstract][Full Text] [Related]
19. Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling.
Cuccurazzu B; Zamberletti E; Nazzaro C; Prini P; Trusel M; Grilli M; Parolaro D; Tonini R; Rubino T
Int J Neuropsychopharmacol; 2018 Nov; 21(11):1014-1024. PubMed ID: 29982505
[TBL] [Abstract][Full Text] [Related]
20. New perspectives in the studies on endocannabinoid and cannabis: abnormal behaviors associate with CB1 cannabinoid receptor and development of therapeutic application.
Fujiwara M; Egashira N
J Pharmacol Sci; 2004 Dec; 96(4):362-6. PubMed ID: 15599103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
